Latest article
Recorlev Additionally Helps to Deal with Diabetes in Cushing’s Syndrome, Trial Finds
Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...